Jagsonpal Pharmaceuticals Ltd Performance
Day's Low
Day's High
₹568.6₹605.9552 Week's Low
52 Week's High
₹273.6₹628.85
| Returns % | |
| 1 Month Return | + 18.33 % |
| 3 Month Return | + 52.84 % |
| 1 Year Return | + 50.41 % |
| Market Stats | |
| Previous Close | ₹576.60 |
| Open | ₹576.00 |
| Volume | 98.58K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹1,527.10Cr |
Jagsonpal Pharmaceuticals Ltd Key Statistics
| P/E Ratio | 0 |
| PEG Ratio | 0 |
| Market Cap | ₹1,527.10 Cr |
| P/B Ratio | 3.95 |
| EPS | 0 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 12.97 |
Jagsonpal Pharmaceuticals Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹1,527.10 Cr | 423.54% | 0.52 | NA | NA | |
| NA | ₹143.16 Cr | 73.55% | 0.56 | NA | NA | |
| NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr | |
| NA | ₹35.53 Cr | 14.76% | 0.54 | NA | NA | |
| NA | ₹111.21 Cr | 51.29% | 0.55 | NA | NA |
About Jagsonpal Pharmaceuticals Ltd
Share Price: ₹592.60 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹1,527.10Cr as of today
Listing date: 13 Sep, 1996
Chairperson Name: Harsha Raghavan
| Organisation | Jagsonpal Pharmaceuticals Ltd |
| Headquarters | Gurgaon |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Jagsonpal Pharmaceuticals Ltd
Jagsonpal Pharmaceuticals Reports Strong Q2 Performance - 07 Nov, 2024
Jagsonpal Pharmaceuticals saw a 29.2% revenue increase in Q2 FY25, with net profit rising 53%. The company plans a stock split pending approval. However, shares have declined 50% in the past month.
Jagsonpal Pharma Shares Rise Ahead of Q2 Results - 17 Oct, 2024
Jagsonpal Pharma shares surged 7% following the announcement of a board meeting on October 23 to discuss Q2 results and a potential stock split.
Jagsonpal Pharmaceuticals Stock Surges Over 15% - 09 Oct, 2024
Jagsonpal Pharmaceuticals Ltd saw its shares surge over 15% on October 9, 2024, marking a significant breakout with the highest single-day trading volume since August 26. The company has a strong history in branded pharmaceutical formulations, particularly in women's healthcare and orthopaedics.
Insights on Jagsonpal Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 0.00% to 0.11% in Sep 2024 quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, JAGSNPHARM has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 1.10% to 2.30% in Sep 2024 quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, JAGSNPHARM stock has moved up by 8.1%
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 8.1%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 30.01% to 29.62% in Sep 2024 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 68.04% to 67.97% in Sep 2024 quarter
Jagsonpal Pharmaceuticals Ltd Financials
Jagsonpal Pharmaceuticals Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 67.97% | ||
| Foreign Institutions | 2.3% | 107.72 | |
| Mutual Funds | 0.11% | 27800.00 | |
| Retail Investors | 29.62% | ||
| Others | 0% |
Jagsonpal Pharmaceuticals Ltd Key Indicators
Jagsonpal Pharmaceuticals Ltd Earnings and Dividends
Jagsonpal Pharmaceuticals Ltd Earnings Results
Jagsonpal Pharmaceuticals Ltd’s net profit jumped 53.41% since last year same period to ₹11.46Cr in the Q2 2024-2025. On a quarterly growth basis, Jagsonpal Pharmaceuticals Ltd has generated 115.01% jump in its net profits since last 3-months.
Read More about Earnings ResultsJagsonpal Pharmaceuticals Ltd Dividends May,2024
In the quarter ending March 2024, Jagsonpal Pharmaceuticals Ltd has declared dividend of ₹5 - translating a dividend yield of 1.73%.
Read More about Dividends
Jagsonpal Pharmaceuticals Ltd Technicals Summary
Bearish
Neutral
Bullish
Jagsonpal Pharmaceuticals Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Jagsonpal Pharmaceuticals Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Jagsonpal Pharmaceuticals Ltd shares.
Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) share price today is ₹592.6
Jagsonpal Pharmaceuticals Ltd is listed on NSE
Jagsonpal Pharmaceuticals Ltd is listed on BSE
- Today’s highest price of Jagsonpal Pharmaceuticals Ltd is ₹605.95.
- Today’s lowest price of Jagsonpal Pharmaceuticals Ltd is ₹568.6.
Today’s traded volume of Jagsonpal Pharmaceuticals Ltd(JAGSNPHARM) is 98.58K.
Today’s market capitalisation of Jagsonpal Pharmaceuticals Ltd(JAGSNPHARM) is ₹1527.1Cr.
| Jagsonpal Pharmaceuticals Ltd(JAGSNPHARM | Price |
|---|---|
52 Week High | ₹628.85 |
52 Week Low | ₹273.6 |
Jagsonpal Pharmaceuticals Ltd(JAGSNPHARM) share price is ₹592.6. It is down -5.76% from its 52 Week High price of ₹628.85
Jagsonpal Pharmaceuticals Ltd(JAGSNPHARM) share price is ₹592.6. It is up 116.59% from its 52 Week Low price of ₹273.6
| Jagsonpal Pharmaceuticals Ltd(JAGSNPHARM | Returns |
|---|---|
1 Day Returns | 16% |
1 Month Returns | 18.33% |
3 Month Returns | 52.84% |
1 Year Returns | 50.41% |